8-K//Current report
G1 Therapeutics, Inc. 8-K
Accession 0001628280-24-019453
CIK 0001560241operating
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 6:38 AM ET
Size
1.6 MB
Accession
0001628280-24-019453
Documents
- 8-Kgthx-20240501.htmPrimary
8-K
- EX-99.1pressrelease-1q24financi.htm
EX-99.1
- EX-101.SCHgthx-20240501.xsd
XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
- EX-101.LABgthx-20240501_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
- EX-101.PREgthx-20240501_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
- GRAPHICpressrelease-1q24financi001.jpg
- GRAPHICpressrelease-1q24financi002.jpg
- GRAPHICpressrelease-1q24financi003.jpg
- GRAPHICpressrelease-1q24financi004.jpg
- GRAPHICpressrelease-1q24financi005.jpg
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001628280-24-019453-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLgthx-20240501_htm.xml
IDEA: XBRL DOCUMENT
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001560241
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 6:38 AM ET
- Size
- 1.6 MB